FDA Inspection 797858 — Amryt Pharmaceuticals, Inc.

Amryt Pharmaceuticals, Inc. — FEI 3009569098

The FDA completed an inspection of Amryt Pharmaceuticals, Inc. on Aug 27, 2012 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Aug 27, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.